Cargando…
A Meta-Analysis of Alzheimer’s Disease Brain Transcriptomic Data
BACKGROUND: Microarray technologies have identified imbalances in the expression of specific genes and biological pathways in Alzheimer’s disease (AD) brains. However, there is a lack of reproducibility across individual AD studies, and many related neurodegenerative and mental health disorders exhi...
Autores principales: | Patel, Hamel, Dobson, Richard J.B., Newhouse, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484273/ https://www.ncbi.nlm.nih.gov/pubmed/30909231 http://dx.doi.org/10.3233/JAD-181085 |
Ejemplares similares
-
Working Towards a Blood-Derived Gene Expression Biomarker Specific for Alzheimer’s Disease
por: Patel, Hamel, et al.
Publicado: (2020) -
Brain Transcriptome Sequencing of a Natural Model of Alzheimer's Disease
por: Altimiras, Francisco, et al.
Publicado: (2017) -
Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid
por: Voyle, Nicola, et al.
Publicado: (2016) -
A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer’s Disease Diagnosis
por: Voyle, Nicola, et al.
Publicado: (2015) -
Meta-Analysis of the Alzheimer’s Disease Human Brain Transcriptome and Functional Dissection in Mouse Models
por: Wan, Ying-Wooi, et al.
Publicado: (2020)